RARE Health Equity Forum 2023
18
Sep
-
19
Sep
2023
When
San Diego
USA
Where

The RARE Health Equity Forum is an annual gathering that brings together various stakeholders within the rare disease space to address the critical issue of health equity. With a specific focus on marginalized populations within the rare disease community, the event aims to identify and implement strategies that can better serve these underserved and underrepresented individuals. Now in its third year, the forum will delve into the theme of "Equity In Action," building upon the learnings and discussions of the previous two years.

The forum recognizes and acknowledges the biases, barriers, and challenges faced by marginalized communities in accessing healthcare and support within the realm of rare diseases. By fostering a collaborative environment, participants will work together to develop more effective approaches to address these challenges head-on. The primary goal of this year's event is to equip attendees with tangible tools and strategic insights that they can apply in their respective communities to support underserved and underrepresented patients.

Through a series of informative sessions, participants will gain actionable knowledge and practical guidance on how to promote health equity within the rare disease landscape. These sessions will explore various topics, including identifying and dismantling systemic barriers, promoting inclusivity and diversity in research and clinical trials, developing patient-centered care models, and advocating for policy changes that address the unique needs of marginalized populations.

By bringing together diverse perspectives and experiences, the RARE Health Equity Forum seeks to foster a collaborative and inclusive space where attendees can learn from one another and contribute to the collective goal of achieving equity in rare disease care. Through this shared dedication and commitment to action, the forum strives to make a meaningful difference in the lives of those who are often overlooked or underserved within the rare disease community.

Similar Events

You May Like

event-img
(0)
02-05 October 2023
15th Annual Immunogenicity & Bioassay Summit
event-img
event-img
(0)
03-05 October 2023
Becker's Chief Medical Information Officer Forum
event-img
event-img
(0)
03-05 October 2023
4th Annual Gene Therapy for Ophthalmic Disorders Summit
event-img
event-img
(0)
03-05 October 2023
38th GS1 Healthcare Global Conference
event-img
event-img
(0)
03-06 October 2023
8th Annual Becker's HIT + DH + RCM Conference
event-img
event-img
(0)
03-06 October 2023
Becker's Patient Experience + Digital Marketing Forum
event-img
event-img
(0)
04-05 October 2023
Becker's CIO + CDO Forum
event-img
event-img
(0)
04-05 October 2023
Future Labs Live USA 2023
event-img
event-img
(0)
04-06 October 2023
LogiPharma USA
event-img
event-img
(0)
05-05 October 2023
7TH ANNUAL AI in Pharma: Clinical Development
event-img

Event

Global Genes

0/5
(0)

Global Genes is a leading rare disease advocacy organization with global reach to the worldwide rare community of patients, caregivers, advocates and clinical partners.

18 - 19 Sep 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Director for Latin America SRF Syngap Research Fund
Program Director
President and CEO
Director, Genetic Education and Navigation
Executive Director
Senior Manager, Product Communications
Director Patient Advocacy Strategy - Center of Rare Disease
Director JumpStart Program
Market Medical Executive

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Genentech

We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal.

The Janssen Pharmaceutical Companies of Johnson & Johnson

At Janssen, we never stop working toward a future where disease is a thing of the past.

Merck

Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases.

Horizon

At Horizon Therapeutics, we believe science and compassion must work together to transform lives.

Travere Therapeutics

At Travere Therapeutics, our mission is to identify, develop and deliver life-changing therapies to people living with rare disease.

Pharming Group N.V.

Pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs.

Harmony Biosciences

At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook.

Avidity Biosciences, Inc.

Our vision is to profoundly improve people’s lives by revolutionizing the delivery of RNA therapeutics.

Amicus Therapeutics

We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Amicus is the Latin word for friend.

Moderna

At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease.

Chiesi Group

Chiesi is an international company originated in Parma, with 85 years of experience and a strong focus on research, development, production and commercialization of innovative therapeutic solutions in the Respiratory, Neonatology, Rare Diseases and S

Organizer

Get emails from us

 
Thank you
Oops! Something went wrong